DOI:
10.1055/s-00000020
Geburtshilfe und Frauenheilkunde
LinksClose Window
References
Lobo C, Lopes G, Baez O. et al.
Final results of a phase II study of nab-paclitaxel, bevacizumab and gemcitabine as first-line therapy for patients with HER2-negative metastatic breast cancer.
Breast Cancer Res Treat 2010;
123: 427-435
Access:
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.